Study Evaluating Vaccine in Adults With HIV

Completed · Phase 1

Conditions studied: HIV Infections

In brief

The purpose of this study is to learn whether the study vaccine and adjuvants (drugs that are used to help improve immune responses) have an acceptable safety profile in treating individuals with HIV. A second purpose of this study is to understand how the immune system responds to the study vaccine and adjuvants.

Key facts

Study ID
NCT00195234
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
60
Starts
2004-12-01
Expected to finish
2007-02-01
Last updated by the study team
2007-12-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.